Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -39.98 |
| peg ratio | -0.40 |
| price to book ratio | -8.80 |
| price to sales ratio | 0.00 |
| enterprise value multiple | -0.57 |
| price fair value | -8.80 |
profitability ratios | |
|---|---|
| gross profit margin | 0.0% |
| operating profit margin | 0.0% |
| pretax profit margin | 0.0% |
| net profit margin | 0.0% |
| return on assets | -170.96% |
| return on equity | 22.54% |
| return on capital employed | 31.54% |
liquidity ratio | |
|---|---|
| current ratio | 0.15 |
| quick ratio | 0.15 |
| cash ratio | 0.07 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.03 |
| operating cycle | 0.03 |
| days of payables outstanding | 146,674.58 |
| cash conversion cycle | -146,674.55 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 11,408.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 1.44 |
| debt equity ratio | -0.18 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | -0.23 |
| interest coverage | -8.87 |
| cash flow to debt ratio | -0.89 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.04 |
| cash per share | 0.01 |
| operating cash flow per share | -0.04 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.89 |
| short term coverage ratios | -0.89 |
| capital expenditure coverage ratio | -766,442.97 |
Frequently Asked Questions
NLS Pharmaceutics AG (NLSP) published its most recent earnings results on 18-10-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. NLS Pharmaceutics AG (NASDAQ:NLSP)'s trailing twelve months ROE is 22.54%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. NLS Pharmaceutics AG (NLSP) currently has a ROA of -170.96%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
NLSP reported a profit margin of 0.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.15 in the most recent quarter. The quick ratio stood at 0.15, with a Debt/Eq ratio of -0.18.